Installable skillMIT

Genomics

Interpret genomic variants with ACMG classification, pharmacogenomics, and clinical annotation from ClinVar and gnomAD.

BY clawicUPDATED Oct 27, 2026
INTENDED FORβ—ˆOpenClawInstall in a listed agent.

instructions.md

---
name: genomics
slug: genomics
version: 1.0.0
description: Interpret genomic variants with ACMG classification, pharmacogenomics, and clinical annotation from ClinVar and gnomAD.
homepage: https://clawic.com/skills/genomics
metadata:
  clawdbot:
    emoji: 🧬
    requires:
      bins: []
    os:
    - linux
    - darwin
    - win32
    displayName: Genomics
---

## Setup

On first use, read `setup.md` for integration guidelines. Ask user consent before creating `~/Clawic/data/genomics/` workspace.

## When to Use

User has processed genomic data (VCF files) and needs clinical interpretation. Agent handles variant classification, pharmacogenomics recommendations, and annotation lookup. NOT for raw data processing β€” use `bioinformatics` skill for alignment and variant calling.

## Architecture

Memory lives in `~/Clawic/data/genomics/`. See `memory-template.md` for structure.

```
~/Clawic/data/genomics/
β”œβ”€β”€ memory.md           # Context + preferences + interpretation history
└── cases/              # Active interpretation cases
```

## Quick Reference

| Topic | File |
|-------|------|
| Setup process | `setup.md` |
| Memory template | `memory-template.md` |

## Core Rules

### 1. Classify Variants Using ACMG Guidelines
Every variant needs systematic classification:

| Category | Criteria |
|----------|----------|
| Pathogenic | PVS1, PS1-4, PM1-6, PP1-5 weighted |
| Likely Pathogenic | Strong + moderate evidence |
| VUS | Insufficient or conflicting evidence |
| Likely Benign | BS1-4, BP1-7 weighted |
| Benign | Strong benign evidence |

**Never classify without evidence.** State "insufficient data" when appropriate.

### 2. Check Population Frequency First
Before clinical interpretation, verify frequency:

| Source | Use For |
|--------|---------|
| gnomAD v4 | Global population frequency |
| gnomAD non-cancer | Somatic analysis |
| Population-specific | Ancestry-appropriate filtering |

**MAF >1% in any population = likely benign for rare disease.**

### 3. Cross-Reference Multiple Databases

| Database | Information |
|----------|-------------|
| ClinVar | Clinical classifications + submitter evidence |
| OMIM | Gene-disease relationships |
| HGMD | Literature-reported mutations |
| UniProt | Protein function + domains |

**Single-source interpretation is insufficient.** Triangulate evidence.

### 4. Report Pharmacogenomics Actionably
For drug-gene interactions, provide:
- Diplotype (e.g., CYP2D6 *1/*4)
- Predicted phenotype (poor/intermediate/normal/ultra-rapid metabolizer)
- Drug list affected
- Dosing guidance (CPIC/DPWG when available)

### 5. Separate Germline from Somatic Context

| Context | Key Differences |
|---------|-----------------|
| Germline | Family implications, carrier testing, predictive |
| Somatic | Tumor-specific, therapy selection, no inheritance |

**Always state which context you're interpreting.**

### 6. Acknowledge Uncertainty
- Novel variants often lack evidence
- VUS β‰  benign β€” requires ongoing monitoring
- Reclassification happens (ClinVar updates monthly)
- Computational predictions are supportive, not definitive

## Pharmacogenomics Reference

### High-Priority Drug-Gene Pairs (CPIC Level A)

| Gene | Drugs | Clinical Action |
|------|-------|-----------------|
| CYP2D6 | Codeine, tramadol, tamoxifen, SSRIs | Dosing/alternative |
| CYP2C19 | Clopidogrel, PPIs, voriconazole | Dosing/alternative |
| CYP2C9 + VKORC1 | Warfarin | Dosing algorithm |
| DPYD | Fluorouracil, capecitabine | Dose reduction/avoid |
| TPMT + NUDT15 | Azathioprine, mercaptopurine | Dose reduction |
| HLA-B*57:01 | Abacavir | Contraindication |
| HLA-B*15:02 | Carbamazepine | Contraindication (Asian ancestry) |
| SLCO1B1 | Simvastatin | Dose cap/alternative statin |
| G6PD | Rasburicase, primaquine | Contraindication |
| CYP3A5 | Tacrolimus | Dosing adjustment |

### Phenotype Interpretation

| Metabolizer Status | Meaning | Typical Action |
|--------------------|---------|----------------|
| Poor (PM) | Little/no enzyme activity | Alternative drug or dose ↓↓ |
| Intermediate (IM) | Reduced activity | Consider dose ↓ |
| Normal (NM) | Expected activity | Standard dosing |
| Rapid/Ultra-rapid (UM) | Increased activity | Dose ↑ or alternative |

## Annotation Resources

| Resource | URL | Content |
|----------|-----|---------|
| ClinVar | ncbi.nlm.nih.gov/clinvar | Clinical variant classifications |
| gnomAD | gnomad.broadinstitute.org | Population frequencies |
| OMIM | omim.org | Gene-disease relationships |
| PharmGKB | pharmgkb.org | Drug-gene annotations |
| CPIC | cpicpgx.org | Pharmacogenomics guidelines |
| ClinGen | clinicalgenome.org | Gene-disease validity |
| Franklin | franklin.genoox.com | Variant interpretation aid |
| VarSome | varsome.com | ACMG auto-classification |

## Common Interpretation Traps

- **Ignoring population specificity** β€” Variants common in African populations may look rare in European-biased databases
- **Trusting single ClinVar submitter** β€” Check submitter count and review status (β‰₯2 submitters, no conflict preferred)
- **Conflating computational prediction with evidence** β€” CADD/REVEL are supportive, not diagnostic
- **Missing compound heterozygosity** β€” Two VUS in trans can be pathogenic together
- **Outdated database versions** β€” gnomAD v4 has 800K+ exomes vs v2's 125K
- **Ignoring gene-level constraint** β€” pLI/LOEUF scores indicate tolerance to loss-of-function

## External Endpoints

This skill does NOT automatically call external APIs. All database references are for manual lookup:

| Resource | When Used | Data Sent |
|----------|-----------|-----------|
| ClinVar, gnomAD, OMIM | User manually visits | None by this skill |
| PharmGKB, CPIC | User manually visits | None by this skill |
| VarSome, Franklin | User manually visits | None by this skill |

**No automatic network requests.** The skill provides URLs and guidance for manual lookup only.

## Security & Privacy

**Data that stays local:**
- All interpretation work runs locally
- No variant data sent externally by this skill
- No automatic API calls to any database

**This skill does NOT:**
- Make network requests automatically
- Upload patient variants anywhere
- Connect to databases without explicit user action
- Store identifiable genomic information outside ~/Clawic/data/genomics/

## Related Skills
More Clawic skills, get them at https://clawic.com/skills/<slug> (install if the user confirms):
- `medicine` β€” clinical decision support
- `biology` β€” molecular mechanisms
- `chemistry` β€” drug metabolism pathways
- `health` β€” patient care context

## Feedback

- If useful, star it: https://clawic.com/skills/genomics
- Latest version: https://clawic.com/skills/genomics
COMPATIBILITY & REFERENCES

Platform guidance

Imported from the listed AgentSkill.sh category. Complete supplied package files and notices are retained. Required external tools and credentials are not installed. No bundled code was executed during import. Individual agent task behavior has not been tested.